Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Sees Large Growth in Short Interest

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) was the target of a large increase in short interest in the month of September. As of September 30th, there was short interest totaling 3,200 shares, an increase of 190.9% from the September 15th total of 1,100 shares. Based on an average daily trading volume, of 4,600 shares, the days-to-cover ratio is currently 0.7 days. Based on an average daily trading volume, of 4,600 shares, the days-to-cover ratio is currently 0.7 days.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on CZMWY. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Carl Zeiss Meditec in a report on Tuesday, August 12th. Barclays started coverage on Carl Zeiss Meditec in a research note on Tuesday, September 9th. They issued an “overweight” rating for the company. Two research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Carl Zeiss Meditec Stock Performance

Shares of Carl Zeiss Meditec stock opened at $54.97 on Tuesday. Carl Zeiss Meditec has a twelve month low of $46.13 and a twelve month high of $76.28. The business has a 50-day moving average price of $51.09 and a 200 day moving average price of $59.25.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.